Hoyoung Huh
Director · PLIANT THERAPEUTICS, INC.
- 2024
- Jun 12, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Hoyoung Huh files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Abizer Gaslightwala - $437K in AKTX purchases and sales in the last 12 months
- Raymond Prudo-Chlebosz - $406K in AKTX purchases and sales in the last 12 months
- Samir Rashmikant Patel - $344K in AKTX purchases and sales in the last 12 months
- Sandip I. Patel - $162K in AKTX purchases and sales in the last 12 months
- Bernard Coulie - $114K in PLRX purchases and sales in the last 12 months
- Robert B. Bazemore - $62K in AKTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Hoyoung Huh?
Hoyoung Huh is a corporate insider, tracked as Director of PLIANT THERAPEUTICS, INC. (PLRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Hoyoung Huh last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 3 filings going back to 2024.
Has Hoyoung Huh been buying or selling stock?
Recorded transactions: 4 open-market purchases ($1.50M) and 0 open-market sales across all tracked filings.
